Skip to main content

Medicine Patent Pool - Pharma Philanthropy or PR?

August 31, 2015

In this peer reviewed editorial for Informa Healthcare, Carmela De Luca discusses a recent agreement between Merck and The Medicines Patent Pool (MPP) to license intellectual property relating to pediatric formulations of its integrase HIV drug. The Agreement is alleged to clear the way for cheaper formulas, novel formulations and combinations, and provide license to manufacture versions of the drug anywhere in the world. However, the Agreement has also been criticized as merely a public relations exercise. De Luca explores this criticism and unpacks the agreement in addressing the question.

Click here to access the article which has been published in final form or email the author for a pre-peer reviewed PDF version.

Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.

Author(s):

Carmela De Luca Carmela De Luca
B.Sc. (Hons. Biochem., Co-op), Ph.D. (Exp. Med.), J.D.
Partner
514.871.2929  email Carmela De Luca